Literature DB >> 30939270

Osteonecrosis of the Hip: A Primer.

Michelle J Lespasio1, Nipun Sodhi2, Michael A Mont2.   

Abstract

In this report, we deliver a concise and up-to-date review of osteonecrosis, a pathologic, painful, and often disabling condition that is believed to result from the temporary or permanent disruption of blood supply to an affected area of bone. We will discuss the epidemiology (disease distribution), pathogenesis (mechanism of development), etiology (associated risk factors, causes, and disorders), clinical manifestations (reported symptoms and physical findings), diagnosis and classification, and treatment options for hip osteonecrosis.

Entities:  

Mesh:

Year:  2019        PMID: 30939270      PMCID: PMC6380478          DOI: 10.7812/TPP/18-100

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  46 in total

Review 1.  Treatment of early stage osteonecrosis of the femoral head.

Authors:  David R Marker; Thorsten M Seyler; Mike S McGrath; Ronald E Delanois; Slif D Ulrich; Michael A Mont
Journal:  J Bone Joint Surg Am       Date:  2008-11       Impact factor: 5.284

Review 2.  Current concepts on osteonecrosis of the femoral head.

Authors:  Joaquin Moya-Angeler; Arianna L Gianakos; Jordan C Villa; Amelia Ni; Joseph M Lane
Journal:  World J Orthop       Date:  2015-09-18

3.  Osteonecrosis of the femoral head: An update in year 2012.

Authors:  Anjan P Kaushik; Anusuya Das; Quanjun Cui
Journal:  World J Orthop       Date:  2012-05-18

4.  Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling.

Authors:  Michael A Mont; Phillip S Ragland; Gracia Etienne
Journal:  Clin Orthop Relat Res       Date:  2004-12       Impact factor: 4.176

5.  Bone marrow concentrate: a novel strategy for bone defect treatment.

Authors:  Marcus Jäger; Eva M Jelinek; Kai M Wess; Axel Scharfstädt; May Jacobson; Sherwin V Kevy; Rüdiger Krauspe
Journal:  Curr Stem Cell Res Ther       Date:  2009-01       Impact factor: 3.828

6.  The orthopedic aspects of Gaucher disease.

Authors:  J Goldblatt; S Sacks; P Beighton
Journal:  Clin Orthop Relat Res       Date:  1978 Nov-Dec       Impact factor: 4.176

7.  Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis.

Authors:  Thorsten M Seyler; David R Marker; Slif D Ulrich; Tobias Fatscher; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2008-05       Impact factor: 4.176

8.  Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE.

Authors:  J Dimant; E M Ginzler; H S Diamond; M Schlesinger; C T Marino; M Weiner; D Kaplan
Journal:  J Rheumatol       Date:  1978       Impact factor: 4.666

Review 9.  High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review.

Authors:  Michael A Mont; Robert Pivec; Samik Banerjee; Kimona Issa; Randa K Elmallah; Lynne C Jones
Journal:  J Arthroplasty       Date:  2015-04-08       Impact factor: 4.757

10.  Management of avascular necrosis of femoral head at pre-collapse stage.

Authors:  Ramesh Kumar Sen
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

View more
  17 in total

1.  The Prevalence of Hip Pathologies in Adolescent Idiopathic Scoliosis.

Authors:  Cole Bortz; Tyler K Williamson; Ammar Adenwalla; Sara Naessig; Bailey Imbo; Lara Passfall; Oscar Krol; Peter Tretiakov; Rachel Joujon-Roche; Kevin Moattari; Navraj Sagoo; Salman Ahmad; Vivek Singh; Stephane Owusu-Sarpong; Shaleen Vira; Bassel Diebo; Peter G Passias
Journal:  J Orthop       Date:  2022-03-10

2.  Influence of obstructive sleep apnea on postoperative cognitive dysfunction in elderly patients undergoing joint replacement.

Authors:  Wei-Qian Wu; Wen-Biao Zheng; Hai-Bao Wang; Jian-Hua Han; Yang Huang; Chong-Yang Wang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  Patient and Disease Related Risk Factors Associated With Return to Sport Rates After AVN Treatment.

Authors:  Patrick England; Julien Y Aoyama; Divya Talwar; Lawrence Wells
Journal:  Iowa Orthop J       Date:  2022-06

4.  The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.

Authors:  Liu-Shan Chen; Meng Zhang; Peng Chen; Xiao-Feng Xiong; Pei-Qing Liu; Hai-Bin Wang; Jun-Jian Wang; Juan Shen
Journal:  Acta Pharmacol Sin       Date:  2021-08-30       Impact factor: 7.169

Review 5.  Avascular Necrosis of Femoral Head-Overview and Current State of the Art.

Authors:  Wojciech Konarski; Tomasz Poboży; Andrzej Śliwczyński; Ireneusz Kotela; Jan Krakowiak; Martyna Hordowicz; Andrzej Kotela
Journal:  Int J Environ Res Public Health       Date:  2022-06-15       Impact factor: 4.614

6.  Rapid and Severe Idiopathic Aseptic Necrosis of the Contralateral Femoral Head after Unilateral Total Hip Arthroplasty.

Authors:  Qihang Su; Yi Zhang; Yuanzhen Zhang; Bin'an Zhao; Heng'an Ge; Peng Wu; Jun Li; Biao Cheng
Journal:  Orthop Surg       Date:  2022-05-07       Impact factor: 2.279

Review 7.  Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A 5-Year Update.

Authors:  Michael A Mont; Hytham S Salem; Nicolas S Piuzzi; Stuart B Goodman; Lynne C Jones
Journal:  J Bone Joint Surg Am       Date:  2020-06-17       Impact factor: 6.558

8.  Disability and functioning in primary and secondary hip osteoarthritis in Benin.

Authors:  Todègnon F Assogba; Didier D Niama-Natta; Toussaint G Kpadonou; Teefany Lawson; Philippe Mahaudens; Christine Detrembleur
Journal:  Afr J Disabil       Date:  2020-11-12

9.  Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis.

Authors:  A Krez; J Lane; A Heilbronner; K-H Park-Min; K Kaneko; T Pannellini; D Mintz; D Hansen; D J McMahon; K A Kirou; G Roboz; P Desai; R S Bockman; E M Stein
Journal:  Osteoporos Int       Date:  2021-04-20       Impact factor: 4.507

Review 10.  Evidence-Supported HBO Therapy in Femoral Head Necrosis: A Systematic Review and Meta-Analysis.

Authors:  Emma Paderno; Vincenzo Zanon; Giuliano Vezzani; Tommaso Antonio Giacon; Thomas L Bernasek; Enrico M Camporesi; Gerardo Bosco
Journal:  Int J Environ Res Public Health       Date:  2021-03-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.